# AOD-9604 / MOTS-c / Tesamorelin Blend

> AOD-9604 / MOTS-c / Tesamorelin Blend combines three peptides studied through distinct pathways related to fat metabolism: AOD-9604, a modified fragment of human growth hormone studied for direct lipolytic activity; MOTS-c, a mitochondrial-derived peptide studied for effects on insulin sensitivity and exercise-like metabolic adaptation; and Tesamorelin, a growth hormone-releasing hormone (GHRH) analog approved in some regions specifically for reducing visceral fat in HIV-associated lipodystrophy. The rationale for combining them is to address fat metabolism from three angles at once, direct lipolysis, cellular energy regulation, and the GH/IGF-1 axis, rather than relying on a single mechanism. Tesamorelin is the only component with formal clinical trial and regulatory history; AOD-9604 and MOTS-c remain investigational. No published research has evaluated the three peptides administered together, so anticipated additive effects are inferred rather than demonstrated.

- URL: https://www.lifeconverted.com/peptides/aod-mots-tesamorelin-blend
- Also known as: AMT Blend, AOD/MOTS-c/Tesa Blend
- Primary category: Weight Loss Blends
- Effectiveness rank: #23 in Weight Management; #13 in Metabolic; #1 in Weight Loss Blends
- Evidence level: Emerging research
- Route: Subcutaneous (All three components are individually studied via subcutaneous injection, consistent with this blend's administration.)
- Dose range: 1-3 mg
- Dose tiers: low 1 mg; moderate 2 mg; high 3 mg
- Half-life: The three components have differing, generally short half-lives: tesamorelin's is on the order of 25-40 minutes, AOD-9604's is similarly brief, and MOTS-c's has been estimated at a few hours in early studies, which is why daily dosing is typically described for this blend.
- Timing: Morning, before exercise
- Cycle: 8-12 weeks on, 4 weeks off (Modeled on cycling patterns described for tesamorelin and AOD-9604 individually. Periodic monitoring of fasting glucose and IGF-1 is commonly suggested given tesamorelin's known effects on the GH axis.)
- Storage: Store lyophilized powder refrigerated (2-8°C) away from light. After reconstitution, keep refrigerated and use within the supplier's stated window, typically 2-4 weeks.

## Mechanism of action

AOD-9604 is proposed to stimulate lipolysis and inhibit lipogenesis in adipose tissue through a mechanism similar to the C-terminal fragment of natural growth hormone, without significantly engaging IGF-1 signaling. MOTS-c is studied for activation of AMP-activated protein kinase (AMPK), a regulator of cellular energy balance linked to glucose uptake and fatty acid oxidation. Tesamorelin binds GHRH receptors on pituitary somatotrophs, stimulating pulsatile growth hormone release and a downstream rise in IGF-1, which in clinical trials was associated with preferential reduction of visceral adipose tissue.

## Reported benefits

- Tesamorelin has clinical trial evidence for visceral fat reduction in a specific approved indication
- AOD-9604 is studied for direct lipolytic activity without the broader GH-axis stimulation associated with growth hormone secretagogues
- MOTS-c is studied for insulin sensitivity and exercise-mimetic metabolic effects
- Combines three distinct fat-metabolism pathways in a single injectable product

## Reported side effects

- Injection site reactions
- Fluid retention, joint pain, or paresthesia, effects documented with tesamorelin in clinical trials
- Changes in blood glucose or insulin sensitivity
- Headache
- Combined effects of the three peptides administered together have not been formally studied

## Common protocols

- Daily subcutaneous injection in a fasted state, often in the morning
- 8-12 week research cycles with periodic body-composition and lab reassessment
- Sometimes paired with structured exercise given MOTS-c's studied exercise-mimetic profile

## Stacking notes

Combining with other GH secretagogues or GHRH analogs is generally discouraged given overlapping effects on IGF-1. Anyone with diabetes, active malignancy, or pituitary disorders should be especially cautious and seek individualized medical guidance.

---

Educational information only, not medical advice. Full disclaimer: https://www.lifeconverted.com/disclaimer